Carotid Plaque Morphologic Characteristics

Perspectives in Vascular Surgery and Endovascular Therapy

Volumn 18, Issue 1, 2006, Pages 63-70

  Aidinian, Gilbert ^a   Weiswasser, Jonathan M ^a   Arora, Subodh ^b   Abularrage, Christopher J ^c   Singh, Niten ^a   Sidawy, Anton N ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

atheromatous plaque; proinflammatory cytokines; vascular smooth muscle cells

Indexed keywords

LOW DENSITY LIPOPROTEIN;

CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; REVIEW; RUPTURE;

CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; RUPTURE, SPONTANEOUS;

EID: 33746096586     PISSN: 15310035     EISSN: None     Source Type: Journal    
DOI: 10.1177/153100350601800124     Document Type: Article

References (51)

1. Stroke statistics-2005. U.S. statistics. The Internet stroke center. www.strokecenter.org. Accessed Sept 4, 2005.
2. European Carotid Surgery Trialists' Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351:1379-1387, 1998.
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995.
4. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 345:209-212, 1995.
5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 325:445-453, 1991.
6. European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (80-99%) or with mild (0-29%) carotid stenosis. Lancet 337:1235-1243, 1991.
7. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1333-1445, 1994.
8. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126, 1999.
9. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 64:5-15, 1991.
10. O'Brien K.D., McDonald T.O., Chait A, et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-I in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996.
11. Hansson G.K., Jonasson L, Seifert P.S., et al. Immune mechanisms in atherosclerosis. Arteriosclerosis 9:567-578, 1989.
12. Reddy V.Y., Zhang Q.Y., Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A 92:3849-3853, 1995.
13. Galis Z.S., Sukhova G.K., Lark M.W., et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994.
14. Loftus I.M., Naylor A.R., Goodall S, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40-47, 2000.
15. Mach F, Schonbeck U, Bonnefoy J.Y., et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD 40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396-399, 1997.
16. Schonbeck U, Mach F, Sukhova G.K., et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD 40 signaling in plaque rupture? Circ Res 81:448-454, 1997.
17. Haberland M.E., Fong D, Cheng L. Malondialdehydealtered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241:215-218, 1988.
18. Yla-Herttuala S, Palinski W, Rosenfeld M.E., et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989.
19. Itabe H, Takeshima E, Iwasaki H, et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 269:15274-15279, 1994.
20. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22:1162-1167, 2002.
21. Manttari M, Manninen V, Huttunen J.K., et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 15:1599-1603, 1994.
22. Nievelstein-Post P, Mottino G, Fogelman A, et al. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb 14:1151-1161, 1994.
23. Liao F, Andalibi A, deBeer F.C., et al. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579, 1993.
24. Leonard E.J., Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101, 1990.
25. Rajavashisth T.B., Andalibi A, Territo M.C., et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254-257, 1990.
26. Cushing S.D., Fogelman AM. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb 12:78-82, 1992.
27. Reid V.C., Mitchinson MJ. Toxicity of oxidized low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 98:17-24, 1993.
28. Heery J.M., Kozak M, Stafforini D.M., et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96:2322-2330, 1995.
29. Fuster V, Stein B, Ambrose J.A., et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82(3 Suppl):II47-II59, 1990.
30. Carr S.C., Farb A, Pearce W.H., et al. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122:757-763; discussion, 763-4, 1997.
31. Geng Y.J., Wu Q, Muszynski M, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16:19-27, 1996.
32. Kockx M.M., Herman AG. Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 19:G23-G28, 1998.
33. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 181:93-99, 1997.
34. Burleigh M.C., Briggs A.D., Lendon C.L., et al. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis 96:71-81, 1992.
35. Davies M.J., Richardson P.D., Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69:377-381, 1993.
36. Fei H, Berliner J.A., Parhami F, et al. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 13:1711-1717, 1993.
37. Jander S, Sitzer M, Wendt A, et al. Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke 32:850-854, 2001.
38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 363:801-809, 1993.
39. Zarins C.K., Giddens D.P., Bharadvaj B.K., et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 53:502-514, 1983.
40. Glagov S, Zarins C, Giddens D.P., et al. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 112:1018-1031, 1988.
41. Chambers B.R., Norris JW. Outcome on patients with asymptomatic neck bruits. N Engl J Med 315:860-865, 1986.
42. O'Holleran L.W., Kennelly M.M., McClurken M, et al. Natural history of asymptomatic carotid plaque. Five-year follow-up study. Am J Surg 154:659-662, 1987.
43. Shaalan W.E., Cheng H, Gewertz B, et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg 40:262-269, 2004.
44. Roederer G.O., Langlois Y.E., Jager K.A., et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 15:605-613, 1984.
45. Persson A.V., Robichaux W.T., Silverman M. The natural history of carotid plaque development. Arch Surg 118:1048-1052, 1983.
46. Golledge J, Greenhalgh R.M., Davies AH. The symptomatic carotid plaque. Stroke 31:774-781, 2000.
47. Gronholdt M.L., Wiebe B.M., Laursen H, et al. Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg 14:439-445, 1997.
48. Patel M.R., Kuntz K.M., Klufas R.A., et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 26:1753-1758, 1995.
49. Rothwell P.M., Salinas R, Ferrando L.A., et al. Does the angiographic appearance of a carotid stenosis predict the risk of stroke independently of the degree of stenosis? Clin Radiol 50:830-833, 1995.
50. Eliasziw M, Streifler J.Y., Fox A.J., et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke 25:304-308, 1994.
51. Rudd J.H., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105:2708-2711, 2002.